CAMBRIDGE, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome
editing company, today announced that it will present a company overview followed by a question and answer session at the
36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018, at 8:30 a.m. PT (11:30 a.m. ET) in San
Francisco, CA.
A live webcast of the presentation and question and answer session will be available on the Investors & Media
section of the Editas Medicine website at www.editasmedicine.com. An archived replay will be available for approximately 30 days
following the presentation.
About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting
their disease-causing genes. The Company was founded by world leaders in genome editing, and its mission is to translate the
promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of
patients. To learn more about Editas Medicine, please visit www.editasmedicine.com.
Contacts
Media:
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com
Investors:
Mark Mullikin
Editas Medicine, Inc.
(617) 401-9083
mark.mullikin@editasmed.com
